Essex Investment Management CO LLC Aerie Pharmaceuticals Inc Transaction History

Essex Investment Management CO LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 04, 2020	SELL	$12.0 - $16.13 $1.2 Million - $1.61 Million	-100,000 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$17.72 - $25.1 $1.77 Million - $2.51 Million	100,000 New	100,000 $2.42 Million
Q3 2019 Oct 22, 2019	SELL	$18.41 - $28.0 $973,391 - $1.48 Million	-52,873 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$28.97 - $48.21 $256,732 - $427,237	-8,862 Reduced 14.35%	52,873 $1.56 Million
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $1.16 Million - $1.57 Million	-31,843 Reduced 34.03%	61,735 $2.93 Million
Q4 2018 Feb 06, 2019	BUY	$33.0 - $60.04 $864,072 - $1.57 Million	26,184 Added 38.85%	93,578 $3.38 Million
Q2 2018 Jul 17, 2018	SELL	$47.85 - $70.45 $463,092 - $681,815	-9,678 Reduced 12.56%	67,394 $4.55 Million
Q4 2017 Feb 05, 2018	SELL	$50.85 - $65.1 $167,499 - $214,439	-3,294 Reduced 4.1%	77,072 $4.61 Million
Q3 2017 Oct 30, 2017	BUY	$48.6 - $60.1 $3.91 Million - $4.83 Million	80,366	80,366 $3.91 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.